Synthesis and Evaluation of 99m Tc-Labeled FAP Inhibitors with Different Linkers for Imaging of Fibroblast Activation Proteins in Tumors
Journal of Medicinal Chemistry · 2023
DOI: 10.1021/acs.jmedchem.2c02062 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2023. Verfasst von Qing Ruan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Radiopharmaceuticals of the Ministry of Education, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (Nationa…. Hauptthemen laut MEDLINE: Diagnostic Imaging, Fibroblasts. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, Beijing Municipal Science and Technology Commission, National Natural Science Foundation of China.
Abstract (Originalsprache)
Fibroblast activation protein (FAP) is a potential target for tumor diagnosis and treatment due to its selective expression on cancer-associated fibroblasts (CAFs) in most solid tumor stroma. Two FAP inhibitor (FAPI) derived ligands (L1 and L2) containing different lengths of DPro-Gly (PG) repeat units as linkers were designed and synthesized with high affinity for FAP. Two stable hydrophilic 99mTc-labeled complexes ([99mTc]Tc-L1 and [99mTc]Tc-L2) were obtained. In vitro cellular studies show that the uptake mechanism is correlated with FAP uptake, and [99mTc]Tc-L1 shows a higher cell uptake and specific binding to FAP. A nanomolar Kd value for [99mTc]Tc-L1 indicates its significantly high target affinity for FAP. The biodistribution and microSPECT/CT images obtained for U87MG tumor mice show that [99mTc]Tc-L1 has high tumor uptake with specificity to FAP and high tumor-to-nontarget ratios. As an inexpensive, easily made, and widely available tracer, [99mTc]Tc-L1 holds great promise for clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Key Laboratory of Radiopharmaceuticals of the Ministry of Education, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), College of Chemistry, Beijing Norm…
- Key Laboratory of Beam Technology of the Ministry of Education, College of Nuclear Science and Technology, Beijing Normal University, Beijing 100875, P. R. China.
ORCID-Profile: Junbo Zhang
Förderung
- China Postdoctoral Science Foundation
- Beijing Municipal Science and Technology Commission
- National Natural Science Foundation of China
Zitieren
APA
Ruan, Q., Wang, Q., Jiang, Y., Feng, J., Yin, G., & Zhang, J. (2023). Synthesis and Evaluation of 99m Tc-Labeled FAP Inhibitors with Different Linkers for Imaging of Fibroblast Activation Proteins in Tumors. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.2c02062
Vancouver
Ruan Q, Wang Q, Jiang Y, Feng J, Yin G, Zhang J. Synthesis and Evaluation of 99m Tc-Labeled FAP Inhibitors with Different Linkers for Imaging of Fibroblast Activation Proteins in Tumors. Journal of Medicinal Chemistry. 2023. doi:10.1021/acs.jmedchem.2c02062
BibTeX
@article{Ruan2023,
author = {Ruan, Qing and Wang, Qianna and Jiang, Yuhao and Feng, Junhong and Yin, Guangxing and Zhang, Junbo},
title = {Synthesis and Evaluation of 99m Tc-Labeled FAP Inhibitors with Different Linkers for Imaging of Fibroblast Activation Proteins in Tumors},
journal = {Journal of Medicinal Chemistry},
year = {2023},
doi = {10.1021/acs.jmedchem.2c02062}
}
EUVIMED